Terpenoid ID | TKC011412 | |
Chirality | TKC151758 | |
Cell line | 0 | |
Protein target | 20 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 55 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC011412 | MRC5 | MRC5; MRC 5; MRCV; MRC-V; Medical Research Council cell strain-5 | 21800.0 | nM | IC50 | ||
TKC011412 | AGS | 89800.0 | nM | IC50 | C4004 | ||
TKC011412 | HepG2 | 41300.0 | nM | IC50 | C3728 | Orphanet_449 | |
TKC011412 | MDA-N | MDAN | 32434.0 | nM | GI50 | C3802 | |
TKC011412 | SN12C | SN-12C | 23988.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC011412 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 19953.0 | nM | GI50 | C3512 | |
TKC011412 | ACHN | 13428.0 | nM | GI50 | C6975 | Orphanet_319298 | |
TKC011412 | UO-31 | UO.31; UO31; U031 | 14355.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC011412 | HOP-92 | HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 | 6223.0 | nM | GI50 | C2926 | |
TKC011412 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 25061.0 | nM | GI50 | C4863 | |
TKC011412 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 18707.0 | nM | GI50 | C3796 | Orphanet_251576 |
TKC011412 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 16181.0 | nM | GI50 | C3510 | |
TKC011412 | K562 | K562; K.562; K 562; KO; GM05372; GM05372E | 28445.0 | nM | GI50 | C9110 | Orphanet_521 |
TKC011412 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 22699.0 | nM | GI50 | C105555 | |
TKC011412 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 11803.0 | nM | GI50 | C9142 | Orphanet_99861 |
TKC011412 | HOP-62 | HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 | 27227.0 | nM | GI50 | C3512 | |
TKC011412 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 13804.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC011412 | NCI/ADR-RES | NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR | 15631.0 | nM | GI50 | C105555 | |
TKC011412 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 20797.0 | nM | GI50 | C105555 | |
TKC011412 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 15346.0 | nM | GI50 | C105555 | |
TKC011412 | MDA-MB-231 | MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 | 31769.0 | nM | GI50 | C5214 | |
TKC011412 | SNB-19 | SNB.19; SNB19; Surgical Neurology Branch-19 | 10000.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC011412 | TK-10 | TK.10; TK 10; TK10 | 13428.0 | nM | GI50 | C4033 | Orphanet_319276 |
TKC011412 | SR | SR-786; SR786 | 5333.0 | nM | GI50 | C37193 | Orphanet_300895 |
TKC011412 | SW-620 | SW-620; SW 620; SW.620 | 31842.0 | nM | GI50 | C4349 | |
TKC011412 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 12972.0 | nM | GI50 | C3512 | |
TKC011412 | KM12 | KM-12; KM.12 | 14028.0 | nM | GI50 | C4910 | |
TKC011412 | NCI-H322M | NCI.H322M; H322M; H-322M; H-322m | 33420.0 | nM | GI50 | C2923 | |
TKC011412 | RPMI-8226 | RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson | 7482.0 | nM | GI50 | C3242 | Orphanet_29073 |
TKC011412 | OVCAR-4 | OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 | 39537.0 | nM | GI50 | C105555 | |
TKC011412 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 19588.0 | nM | GI50 | C3802 | |
TKC011412 | BT-549 | BT 549; BT.549; BT549 | 10544.0 | nM | GI50 | C4194 | |
TKC011412 | SK-MEL-2 | SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 | 18923.0 | nM | GI50 | C3224 | |
TKC011412 | A549 | 18197.0 | nM | GI50 | C3512 | ||
TKC011412 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 17824.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC011412 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 13243.0 | nM | GI50 | C4349 | |
TKC011412 | HCT-15 | HCT-15; HCT.15; HCT15 | 27290.0 | nM | GI50 | C4349 | |
TKC011412 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 8670.0 | nM | IC50 | C4910 | |
TKC011412 | SF-268 | SF-268; SF.268; SF 268 | 18836.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC011412 | PC-3 | PC3; PC.3 | 15311.0 | nM | GI50 | C4863 | |
TKC011412 | MCF7 | 18880.0 | nM | GI50 | C4194 | ||
TKC011412 | EKVX | 15885.0 | nM | GI50 | C3512 | ||
TKC011412 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 37325.0 | nM | GI50 | C7978 | |
TKC011412 | T47D | 18408.0 | nM | GI50 | C4194 | ||
TKC011412 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 19861.0 | nM | GI50 | C4450 | |
TKC011412 | UACC-62 | UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 | 13868.0 | nM | GI50 | C3224 | |
TKC011412 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 27797.0 | nM | GI50 | C3224 | |
TKC011412 | MDA-MB-435 | MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 | 16255.0 | nM | GI50 | C3802 | |
TKC011412 | IGROV-1 | Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P | 19409.0 | nM | GI50 | C7979 | Orphanet_454723 |
TKC011412 | SF-295 | SF-295; SF.295; SF 295 | 22387.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC011412 | Hs-578T | HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells | 24099.0 | nM | GI50 | C4194 | |
TKC011412 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 14555.0 | nM | GI50 | C3224 | |
TKC011412 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 30974.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC011412 | CCRF-CEM | CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C | 3184.0 | nM | GI50 | C7953 | Orphanet_99861 |
TKC011412 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 10351.0 | nM | GI50 | C45662 | Orphanet_50251 |
TKC011412 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 13152.0 | nM | GI50 | C3510 | |
TKC011412 | HT-29 | HT 29; HT29 | 20190.0 | nM | IC50 | C4349 | |
TKC011412 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 19634.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC011412 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 24155.0 | nM | GI50 | C4349 | |
TKC011412 | Hepatocyte | 95700.0 | nM | EC50 | |||
TKC011412 | PANC-1 | Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1; Panc-1-P | 150000.0 | nM | EC50 | C9120 | |
TKC011412 | MIA PaCa-2 | MIA-PaCa-2; MIA-PACA-2; MIA-Pa-Ca-2; MIA Paca2; MIA PaCa2; MiaPaCa-2; MIAPACA-2; MiaPaca.2; MiaPaCa2; Miapaca2; MIAPaCa2; MIAPACA2; Mia PACA 2; MIAPaCa-2; PaCa2; MiaPaCa | 5500.0 | nM | EC50 | C9120 | |
TKC011412 | SW480 | SW-480; SW 480; SW480E | 10490.0 | nM | IC50 | C4349 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC011412 | P00352 | Retinal dehydrogenase 1 | ALDH1A1 | 14125 | nM | Potency |
TKC011412 | P10636 | Microtubule-associated protein tau | MAPT | 8913 | nM | Potency |
TKC011412 | P11473 | Vitamin D3 receptor | VDR | 19953 | nM | Potency |
TKC011412 | P08684 | Cytochrome P450 3A4 | CYP3A4 | 4300 | nM | Ki |
TKC011412 | O14684 | Prostaglandin E synthase | PTGES | 5000 | nM | IC50 |
TKC011412 | P14324 | Farnesyl pyrophosphate synthase | FDPS | 20000 | nM | IC50 |
TKC011412 | P16233 | Pancreatic triacylglycerol lipase | PNLIP | 36000 | nM | IC50 |
TKC011412 | Q72874 | Protease | pol | 240 | nM | IC50 |
TKC011412 | P05177 | Cytochrome P450 1A2 | CYP1A2 | <11 | % | Inhibition |
TKC011412 | P05181 | Cytochrome P450 2E1 | CYP2E1 | <11 | % | Inhibition |
TKC011412 | P10635 | Cytochrome P450 2D6 | CYP2D6 | <11 | % | Inhibition |
TKC011412 | P11712 | Cytochrome P450 2C9 | CYP2C9 | 9200 | nM | Ki |
TKC011412 | P33261 | Cytochrome P450 2C19 | CYP2C19 | <11 | % | Inhibition |
TKC011412 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 3548 | nM | Potency |
TKC011412 | O00255 | Menin | MEN1 | 22387 | nM | Potency |
TKC011412 | O15296 | Polyunsaturated fatty acid lipoxygenase ALOX15B | ALOX15B | 355 | nM | Potency |
TKC011412 | O97447 | Putative fructose-1,6-bisphosphate aldolase | fba | 9976 | nM | Potency |
TKC011412 | P02791 | Ferritin light chain | FTL | 25119 | nM | Potency |
TKC011412 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | HPGD | 15849 | nM | Potency |
TKC011412 | Q9F4F7 | 4'-phosphopantetheinyl transferase ffp | ffp | 1413 | nM | Potency |
TKC011412 | P18054 | Polyunsaturated fatty acid lipoxygenase ALOX12 | ALOX12 | 1995 | nM | Potency |
TKC011412 | P35222 | Catenin beta-1 | CTNNB1 | 5213 | nM | IC50 |
TKC011412 | P51450 | Nuclear receptor ROR-gamma | Rorc | 15849 | nM | Potency |
TKC011412 | P0A0J7 | Quinolone resistance protein NorA | norA | 2 | ug.mL-1 | MIC |
TKC011412 | P10632 | Cytochrome P450 2C8 | CYP2C8 | <11 | % | Inhibition |
TKC011412 | P20813 | Cytochrome P450 2B6 | CYP2B6 | <11 | % | Inhibition |
TKC011412 | P78417 | Glutathione S-transferase omega-1 | GSTO1 | 62000 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P10636 | TAU_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 | TAU_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P10636 | TAU_HUMAN | Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 | TAU_HUMAN | Choreiform disorder [ICD-11: 8A01] |
P10636 | TAU_HUMAN | Parkinsonism [ICD-11: 8A00] |
P10636 | TAU_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 | TAU_HUMAN | Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P11473 | VDR_HUMAN | Chronic kidney disease [ICD-11: GB61] |
P11473 | VDR_HUMAN | Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 | VDR_HUMAN | Hyper-parathyroidism [ICD-11: 5A51] |
P11473 | VDR_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
P11473 | VDR_HUMAN | Mineral deficiency [ICD-11: 5B5K] |
P11473 | VDR_HUMAN | Psoriasis [ICD-11: EA90] |
P11473 | VDR_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 | VDR_HUMAN | Low bone mass disorder [ICD-11: FB83] |
P11473 | VDR_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 | VDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
P11473 | VDR_HUMAN | Prostate disease [ICD-11: GA91] |
P11473 | VDR_HUMAN | Abnormal micturition [ICD-11: MF50] |
P11473 | VDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 | VDR_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 | VDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
P08684 | CP3A4_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08684 | CP3A4_HUMAN | Atopic eczema [ICD-11: EA80] |
P08684 | CP3A4_HUMAN | Anxiety disorder [ICD-11: 6B00-6B0Z] |
O14684 | PTGES_HUMAN | Alzheimer disease [ICD-11: 8A20] |
O14684 | PTGES_HUMAN | Circulatory system disease [ICD-11: BE2Z] |
O14684 | PTGES_HUMAN | Joint pain [ICD-11: ME82] |
O14684 | PTGES_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P14324 | FPPS_HUMAN | Bone paget disease [ICD-11: FB85] |
P14324 | FPPS_HUMAN | Focal/segmental autonomic disorder [ICD-11: 8D8A] |
P14324 | FPPS_HUMAN | Low bone mass disorder [ICD-11: FB83] |
P14324 | FPPS_HUMAN | Mineral excesses [ICD-11: 5B91] |
P14324 | FPPS_HUMAN | Musculoskeletal system/connective tissue disease [ICD-11: FC0Z] |
P14324 | FPPS_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P14324 | FPPS_HUMAN | Colorectal cancer [ICD-11: 2B91] |
P14324 | FPPS_HUMAN | Mature T-cell lymphoma [ICD-11: 2A90] |
P14324 | FPPS_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
P14324 | FPPS_HUMAN | Myeloproliferative neoplasm [ICD-11: 2A20] |
P14324 | FPPS_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P14324 | FPPS_HUMAN | Sexually transmitted infection [ICD-11: 1A9Y-1A9Z] |
P14324 | FPPS_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P16233 | LIPP_HUMAN | Bacterial infection [ICD-11: 1A00-1C4Z] |
P16233 | LIPP_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P16233 | LIPP_HUMAN | Pancreatic malfunction [ICD-11: DC30-DC3Z] |
P16233 | LIPP_HUMAN | Cystic fibrosis [ICD-11: CA25] |
P16233 | LIPP_HUMAN | Pancreas disease [ICD-11: DC35-DC3Z] |
P10635 | CP2D6_HUMAN | Insomnia [ICD-11: 7A00-7A0Z] |
P10635 | CP2D6_HUMAN | Malaria [ICD-11: 1F40-1F45] |
P10635 | CP2D6_HUMAN | Migraine [ICD-11: 8A80] |
P11712 | CP2C9_HUMAN | Bacterial infection [ICD-11: 1A00-1C4Z] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35222 | CTNB1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35222 | CTNB1_HUMAN | Colon cancer [ICD-11: 2B90] |
P35222 | CTNB1_HUMAN | Systemic sclerosis [ICD-11: 4A42] |
P78417 | GSTO1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |